AzTrials
AzTrials

Cerebral PalsyPurple-NNCT03499288

Profiling Children and Youth With Cerebral Palsy in Relation to Feeding and Nutrition

An observational study of Cerebral Palsy, run by Nutricia Research at 20 sites in 8 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

HCPs will complete questionnaires about their patients with Cerebral Palsy (CP) and invite parents/caregivers of these patients to fill in questionnaires as well. Questionnaires include questions on individualized treatment, nutritional profile and management, and patient characteristics. Read more about this study

Who is it for?
Ages 1 month to 17 years
Conditions the study is for
Cerebral Palsy
How many people
499 participants
Where
20 sitesin 8 countries
Study dates
11 Apr 2017to 3 Jul 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Subjects between 1 month and 18 years of age with Cerebral Palsy

Who may be able to join

  • Confirmed diagnosis of Cerebral Palsy
  • Age<18 years
  • Have visited the HCP within the last year
  • Written informed consent provided by parents/legal representatives according to local law

Who cannot join

  • Neurodegenerative diseases
  • Acute infections: meningitis, encephalitis or poliomyelitis

Trial locations and contacts

20 sites in 8 countries.

20 sites in 8 countries

Turkey (Türkiye)9 sites
  • Ankara University School of Medicine/Neurology

    Ankara

  • Gazi University School of Medicine/Neurology

    Ankara

  • Hacettepe University School of Medicine/Neurology

    Ankara

  • Ege University School of Medicine/Neurology

    Ege

  • Eskisehir Osmangazi University School of Medicine/Neurology

    Eskişehir

  • Inonu University School of Medicine/Neurology

    İnönü

  • Dokuz Eylul University School of Medicine/Neurology

    Izmir

  • Marmara University School of Medicine/Neurology

    Marmara

  • Mersin University School of Medicine/Neurology

    Mersin

Other trials in Turkey (Türkiye)

Italy4 sites
  • AO Sant'Orsola - Malpighi, Policlinico

    Bologna

  • ASST degli Spedali Civili di Brescia

    Brescia

  • Fondazione IRCCS Istituto Neurologico "Carlo Besta"

    Milan

  • AOU di Modena - Policlinico

    Modena

Other trials in Italy

Poland2 sites
  • Medical university hospital of Gdansk

    Gdansk

  • Szpital Kliniczny im. Heliodora Święcickiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu

    Poznan

Other trials in Poland

Czechia1 site
  • Fakultní nemocnice v Motole

    Prague

Other trials in Czechia

Greece1 site
  • Attikon University General Hospital

    Athens

Other trials in Greece

Hungary1 site
  • Bethesda Children Hospital Budapest

    Budapest

Other trials in Hungary

Netherlands1 site
  • Roessingh centrum voor Revalidatie

    Enschede

Other trials in Netherlands

Slovakia1 site
  • Fakultná nemocnica Trnava

    Trnava

Other trials in Slovakia

About this study

Official title: A Multi-country, Multi-centre, Observational, Cross-sectional Study to Evaluate Individualized Treatment and Management in Children and Adolescents With Cerebral Palsy

HCPs will complete questionnaires about their patients with Cerebral Palsy (CP) and invite parents/caregivers of these patients to fill in questionnaires as well. Questionnaires include questions on individualized treatment, nutritional profile and management, and patient characteristics.

Read the detailed description

Coordinating health care professionals (HCPs; e.g. paediatric neurologists, physiotherapists) in different centres across different countries will be asked to participate in this cross-sectional study.

  1. for the HCP to fill out a questionnaire about their CP child, related to general subject characteristics, motor function, co-morbidities, type of therapies, anthropometry, feeding mode and nutritional status; and B) for parents (/legal representatives) to receive and fill out questionnaires about their CP child and themselves, related to general subject characteristics, motor function, co-morbidities, type of therapies, anthropometry, feeding mode and nutritional status, participation and (their own) quality of life.

If parents (/legal representatives) agree to "A)", but not "B)" then a subject will still enter the study, but without the parental assessment.

Conditions
Cerebral Palsy
Keywords
Cerebral Palsy
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03499288
Study groupRoleWhat they receive
Children and youth with cerebral palsySubjects between 1 month and 18 years of age with Cerebral Palsy who visited the coordinating HCP within the past 12 months.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quantify current CP characteristics 1 (general subject characteristics):

    Using questionnaires to quantify current CP characteristics with respect to:

    • General subject characteristics (e.g. Sex, Birth weight [g], Type of CP motor disorder [category]

    Measured: Data collected retrospectively, from within 12 months of entering the questionnaire

  2. Quantify current CP characteristics 2 (anthropometry):

    Using questionnaires to quantify current CP characteristics with respect to:

    Anthropometry: length [cm]; weight [grams] and BMI (kg/m2)

    Measured: Data collected retrospectively, from within 12 months of entering the questionnaire

  3. Quantify current CP characteristics 3 (motor function)

    Using questionnaires to quantify current CP characteristics with respect to:

    Motor function (GMFCS [category]; GMFM measurement type [GMFM-86/GMFM-88]

    Measured: Data collected retrospectively, from within 12 months of entering the questionnaire

  4. Quantify current CP characteristics 4 (comorbidities)

    Using questionnaires to quantify current CP characteristics with respect to:

    Comorbidities: epilepsy, cognitive function, GI problems [categories]

    Measured: Data collected retrospectively, from within 12 months of entering the questionnaire

  5. Quantify current CP characteristics 5 (therapies)

    Using questionnaires to quantify current CP characteristics with respect to:

    Type and frequency of physical/occupational therapy [type, number of hours per day /days per week]

    Measured: Data collected retrospectively, from within 12 months of entering the questionnaire

  6. Quantify current CP characteristics 6 (feeding mode)

    Using questionnaires to quantify current CP characteristics with respect to:

    Feeding mode and/or problems (tube feeding [yes/no], type of tube feeding etc)

    Measured: Data collected retrospectively, from within 12 months of entering the questionnaire

  7. Quantify current CP characteristics 7 (nutritional status)

    Using questionnaires to quantify current CP characteristics with respect to:

    Nutritional status (HCP and parent perspective on nutritional status, concerns [yes/no])

    Measured: Data collected retrospectively, from within 12 months of entering the questionnaire

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2018
  2. Study start11 Apr 2017
  3. Primary completion3 Jul 2018
  4. Study completion3 Jul 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
499 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03499288
Sponsor's protocol ID
MPR15FA89628
Acronym
Purple-N
Status last verified
Nov 2018
First submitted
21 Mar 2018
Last updated
16 Nov 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Fogarasi A, Fazzi E, Smorenburg ARP, Mazurkiewicz-Beldzinska M, Dinopoulos A, Pobiecka A, Schroder-van den Nieuwendijk D, Kraus J, Tekgul H; PURPLE N study group; Czech Republic:; Kraus J; Greece:; Dinopoulos A, Koutsaki M; Hungary:; Fogarasi A; Italy:; Baranello G, Bertoli S, Caramaschi E, Cordelli DM, De Amicis R, Fazzi E, Forchielli ML, Guerra A, Lividini A, Marchio M, Rossi A; Netherlands:; Nieuwendijk DSD; Poland:; Flicinski J, Gurda B, Lemska A, Matheisel A, Mazurkiewicz-Beldzinska M, Niwinska Z, Pawlowicz M, Sawicka A, Steinborn B, Szmuda M, Winczewska-Wiktor A, Zawadzka M; Slovakia:; Pobiecka A; Turkey:; Arhan E, Aydin K, Bayram E, Carman KB, Edem P, Ertem D, Goktas OA, Gungor S, Haliloglu G, Kansu A, Komur M, Mutlu A, Kirsaclioglu CT, Okuyaz C, Ozgor B, Ozturk Y, Sager SG, Sarigecili E, Selimoglu MA, Serin HMO, Teber ST, Tekgul H, Thomas G, Turkdogan D, Volkan B, Yarar C, Yilmaz SK. The PURPLE N study: objective and perceived nutritional status in children and adolescents with cerebral palsy. Disabil Rehabil. 2022 Nov;44(22):6668-6675. doi: 10.1080/09638288.2021.1970255. Epub 2021 Sep 2.

    PubMed 34473588

Questions about this trial

What is this clinical trial studying?

An observational study of Cerebral Palsy, run by Nutricia Research at 20 sites in 8 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Nov 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 20 sites in Turkey (Türkiye), Italy, Poland, Czechia, Greece and 3 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quantify current CP characteristics 1 (general subject characteristics): (time frame: Data collected retrospectively, from within 12 months of entering the questionnaire). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03499288, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Nov 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in